Cancer/testis antigen 1 (124-134)

Cancer/testis antigen 1 (124-134) is a synthetic peptide fragment derived from the cancer/testis antigen family, specifically representing amino acid residues 124 to 134 of the parent protein. These antigens are notable for their restricted expression profile, being predominantly found in various malignancies and in testicular tissue, but not in most normal somatic tissues. As a well-characterized epitope, the 124-134 region is frequently studied for its immunogenic properties, making it a valuable tool for investigations into tumor immunology, antigen processing, and immune recognition. The peptide's defined sequence facilitates its application in a range of experimental systems, supporting both fundamental and translational research efforts focused on antigen presentation and immune targeting.

Immunological research: The 124-134 peptide fragment is extensively utilized in studies exploring antigen-specific T cell responses. Its defined sequence allows researchers to investigate how cytotoxic T lymphocytes recognize and respond to tumor-associated antigens, providing insights into the mechanisms by which the immune system distinguishes malignant cells from normal tissue. By serving as a model epitope, the peptide supports the development and optimization of assays such as ELISPOT, intracellular cytokine staining, and tetramer-based flow cytometry, which are essential for characterizing T cell specificity and function.

Epitope mapping: The peptide serves as a critical reagent in epitope mapping experiments aimed at delineating the precise regions within cancer/testis antigens that are recognized by the immune system. By systematically analyzing T cell or antibody reactivity to overlapping peptide fragments, researchers can identify immunodominant determinants and characterize the molecular basis of antigen recognition. Such studies inform the rational design of antigenic constructs for immunotherapy and vaccine development, as well as the selection of biomarkers for cancer diagnostics.

Antigen processing studies: As a synthetic peptide corresponding to a naturally processed epitope, the 124-134 fragment is instrumental in dissecting the pathways by which tumor antigens are generated, processed, and presented on major histocompatibility complex (MHC) molecules. Using this peptide in cell-based assays enables researchers to bypass upstream proteolytic processing steps, allowing direct assessment of peptide-MHC binding, stability, and recognition by immune effector cells. These investigations are fundamental to understanding immune surveillance and the evasion strategies employed by cancer cells.

Peptide-based assay development: The defined nature of the 124-134 sequence makes it an ideal standard for developing and validating peptide-based immunoassays. It can be incorporated into protocols for the quantitative detection of antigen-specific immune responses, including enzyme-linked immunosorbent assays (ELISA) and multiplex bead-based platforms. By providing a reliable and reproducible antigenic stimulus, the peptide facilitates assay calibration, sensitivity testing, and inter-laboratory standardization, which are essential for robust immunomonitoring in both preclinical and research settings.

Peptide synthesis and modification studies: The 124-134 fragment also serves as a template for investigating the effects of sequence modifications, post-translational mimetics, or chemical conjugation on peptide stability, immunogenicity, and functional properties. Researchers can employ the peptide in structure-activity relationship studies, exploring how alterations in amino acid composition or the introduction of non-natural residues influence antigen recognition and immune activation. Such work supports the rational design of next-generation peptide reagents with improved performance for research and biotechnological applications.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

5. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment